Female Urogenital Diseases and Pregnancy Complications

217 trials 111 recruiting

Filter these 217 trials by phase, country and sponsor.

Open in Search →

PREMI trial Recruiting

2023-503220-76-01 Unexplained recurrent miscarriages 6 2024-02-13
Preeclampsia Intervention 4 Recruiting

2022-502707-29-00 Preeclampsia 5 2024-02-07
Neo-adjuvant pembroliuzmab as an alternative treatment for MMRd uterine cancer Recruiting

2024-516736-10-00 Mismatch repair deficient endometrial cancer / uterine 4 2023-12-18
Insemination in patients with polycystic ovary syndrome: gestation rates using two stimulation patterns: letrozole vs gonadotropins. Recruiting

2023-503477-38-00 Insemination in patients with polycystic ovary syndrome 5 2023-12-15
Mifepristone and Letrozole in Ectopic Pregnancy (MILE) Recruiting

2023-503935-16-00 Ectopic pregnancy 4 2023-12-15
INtensity of OVarian stimualtion and Euploid Embryos (INOVEE Study) Recruiting

2023-507028-22-00 Infertility 6 2023-12-12
PRO_NAT Recruiting

2023-504188-18-00 Women undergoing ovarian stimulation for oocyte donatio 6 2023-11-08
Patient-controlled sedation during repair of obstetric perineal lacerations Recruiting

2022-502292-39-00 Obstetric perineal lacerations 5 2023-09-19
Aspirin for the Prevention of Preeclampsia and Pregnancy outcomes in nulliparous women after Assisted Reproductive Technology. Recruiting

2022-500933-10-00 Preeclampsia during pregnancy 11 2023-08-02
A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of two formulations of vaginal micronized progestero… Recruiting

2024-513102-57-00 infertility 5 2023-07-05
HYPATIA: A prospective randomised controlled trial of HYdroxychloroquine to improve Pregnancy outcome in women with AnTIphospholipid Antibod… Recruiting

2023-504661-23-00 Antiphospholipid antibodies 5 2023-06-27
A study of different dose levels of FluBHPVE6E7 or placebo in women infected with the virus Human Papilloma Type 16 (HPV 16). Recruiting

2024-515535-30-00 Treatment of human papilloma virus (HPV) associated inf 3 2023-06-22
Measuring Oncological Value of Exercise and Statin (MOVES) Recruiting

2024-515109-24-00 Metastatic breast, ovarian, prostate and kidney cancer 5 2023-03-31
Aspirin versus placebo in twin pregnancies for preeclampsia prevention: A multicentre, randomised, double-blind, placebo-controlled trial (A… Recruiting

2023-503698-40-00 Preeclampsia 5 2023-03-23
MAintenance Therapy with Aromatase inhibitor in epithelial Ovarian cancer Recruiting

2024-511219-78-00 epithelial ovarian cancer 5 2023-02-28
Combined treatment of intraperitoneal chemotherapy after optimal interval surgery in advanced ovarian cancer. BICOV-1 (Bidirectional Chemoth… Recruiting

2022-502691-23-00 Ovarian cancer 6 2023-02-27
Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN). Recruiting

2023-507233-19-00 Treatment of IgAN 10 2023-02-16
Luteal phase ovarian stimulation with Follitropin delta and dydrogesterone Recruiting

2024-513998-48-00 Volutary women who wish to donate their oocytes 6 2023-02-02
OPTION – OutPatienT InductiON: Labour induction in an outpatient setting - a multicentre randomized controlled trial Recruiting

2023-507164-39-00 Induction of labour 6 2021-12-01
Impact of Exercise and Mediterranean diet vs Aspirin on live-birth rate and cardiovascular programming in In Vitro Fertilization (MEDITATE-I… Recruiting

2024-515590-10-00 Women infertility 5 2021-09-16
CHASAP : Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy, a multicenter prospective randomized double-blind placebo-controlled t… Recruiting

2024-516461-36-00 Pregnancy associated hypertension, Pre-Eclampsia, Fetal 5 2021-01-27
GROINSS-V III Recruiting

2023-508722-99-00 Vulvar cancer 4 2020-11-19
TRAnexamic Acid for Preventing blood loss following a cesarean delivery in women with placenta pREVIA: a multicenter randomised, double blin… Recruiting

2024-515276-12-00 Postpartum Hemorrhage 5 2020-07-01
Intravesical instillation therapy with bacillus Calmette-Guérin (BCG) and sequential BCG and electromotive mitomycin-C (EMDA-MMC) in patient… Recruiting

2024-516320-33-00 Bladder cancer 5 2019-01-07